Please login to the form below

Not currently logged in
Email:
Password:

Symdeko

This page shows the latest Symdeko news and features for those working in and with pharma, biotech and healthcare.

Vertex scores FDA approval for CF triple therapy Trikafta

Vertex scores FDA approval for CF triple therapy Trikafta

and Symkevi/Symdeko (tezacaftor/ivacaftor) – which can treat around half of patients. ... The list price of $311, 000 is more than Leerink analyst Geoffrey Porges' prediction that the triple therapy could be priced similarly to Symdeko, which costs $233

Latest news

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics